Thursday 26th June 2008 |
Text too small? |
The companies had previously estimated synergy benefits from a merger of NZ$7.6 million, Christie said in a statement today.
The merged company, called ProvencoCadmus Ltd, will post an ebitda loss of about NZ$10 million for the 12 months ended June 30, reflecting one-time restructuring costs.
ProvencoCadmus said in May it would cut about 100 workers, or 25% of its staff to reduce costs and duplication between the two former rivals. The company plans to raise capital in the first quarter of 2009 and is also considering the sale of some non-core assets, it said.
Shares of ProvencoCadmus rose 4% to 26 New Zealand cents. They traded at NZ1.15 at the beginning of 2007.
No comments yet
December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors